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Abstract
Background: This study was to validate the feasibility of using clinical 3.0T MRI to monitor the migration of
autotransplanted bone marrow (BM)-derived stem-progenitor cells (SPC) to the injured arteries of near-human sized swine
for potential cell-based arterial repair.
Methodology: The study was divided into two phases. For in vitro evaluation, BM cells were extracted from the iliac crests of
13 domestic pigs and then labeled with a T2 contrast agent, Feridex, and/or a fluorescent tissue marker, PKH26. The viability,
the proliferation efficiency and the efficacies of Feridex and/or PKH26 labeling were determined. For in vivo validation, the
13 pigs underwent endovascular balloon-mediated intimal damages of the iliofemoral arteries. The labeled or un-labeled
BM cells were autotransplanted back to the same pig from which the BM cells were extracted. Approximately three weeks
post-cell transplantation, 3.0T T2-weighted MRI was performed to detect Feridex-created signal voids of the transplanted
BM cells in the injured iliofemoral arteries, which was confirmed by subsequent histologic correlation.
Principal Findings: Of the in vitro study, the viability of dual-labeled BM cells was 95–98%. The proliferation efficiencies of
dual-labeled BM cells were not significantly different compared to those of non-labeled cells. The efficacies of Feridex- and
PKH26 labeling were 90% and 100%, respectively. Of the in vivo study, 3.0T MRI detected the auto-transplanted BM cells
migrated to the injured arteries, which was confirmed by histologic examinations.
Conclusion: This study demonstrates the capability of using clinical 3.0T MRI to monitor the auto-transplantation of BM cells
that migrate to the injured arteries of large animals, which may provide a useful MRI technique to monitor cell-based arterial
repair.
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Introduction
Atherosclerotic cardiovascular disease is still the leading cause of
death in developed countries [1]. One of the characteristic features
of the disease is its diffuse involvement of arteries across the entire
human body and the simultaneous presence of multiple athero-
sclerotic lesions or plaques. Rupture of plaques is often lethal,
causing myocardial infarction or stroke, which are responsible for
over 50% of all death around the world.
Surgery-based artery bypass grafting and percutaneous trans-
arterial interventions are currently available methods for reducing
the risk of myocardial infarction and stroke from atherosclerotic
cardiovascular disease. However, these methods have their
drawbacks. Surgical bypass grafting is an invasive approach, while
percutaneous transarterial intervention only offers local treatment
of limited numbers of atherosclerotic arterial segments. Thus, it is
necessary to develop new or alternative methods to treat the
multiple and diffused atherosclerotic plaques, stabilize vulnerable
plaques, and repair ruptured plaques in their ‘‘fresh state’’.
Recent studies have shown that injured or ruptured atheroscle-
rotic lesions can recruit circulating bone marrow (BM)-derived
stem-progenitor cells (SPCs) that are capable of differentiation into
proliferating smooth muscle cells (SMCs) and endothelial cells
(ECs)[2]. Another important report is that intravenously trans-
fused BM-SPCs can specifically migrate to atherosclerotic lesions
[3]. Based on these observations, the concept of ‘‘cell-based
arterial repair and plaque stabilization’’ may emerge. In theory,
SPCs can be used to stabilize or repair plaques based on their
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ECs, which can secrete extracellular matrix rich in glycosamino-
glycans and collagen [4]. All of these elements may contribute to
strengthen the fibrous caps of plaques and maintain the integrity of
the endothelial layer to prevent additional damage to the arterial
wall.
Studies have established the ‘‘proofs-of-principal’’ of using MRI
to monitor, in vivo, the trafficking of BM-SPCs to the injured
arteries or atherosclerotic plaques for potential repair of injured
arteries and vulnerable atherosclerotic lesions [5–7]. However,
these studies were performed in small animals with allo-
transplantation of BM-SPCs from donors, which may increase
the risk of immunological rejection, and therefore, limit its clinical
application on humans. Autologous cell transplantation is one of
strategies to solve this problem. The aim of this study was to
validate the feasibility of using clinical 3.0T MRI to monitor the
migration of autotransplanted BM-SPCs to the injured arteries of
large animals, which might open new avenues for cell-based
arterial repair under MRI guidance.
Results
For the in vitro evaluation, Trypan blue exclusion showed the
viabilities of the labeled cells at 95–98%. Regarding the metabolic
rate, MTS assay confirmed no significant difference among the
Feridex-labeled cell group (0.31960.072), PKH26-labeled cell
group (0.30460.059), Feridex/PKH26 dual labeled cell group
(0.30760.062), and the control cell group (with no labeling,
0.31960.069)(Figure 1). The cell labeling efficacy was achieved at
approximately 90% for Feridex and 100% for PKH26. Prussian
blue stain displayed Feridex-positive cells as blue-colored spots,
and fluorescent microscopy showed PKH26-positive cells as red-
colored dots (Figure 1).
For the in vivo validation, all 13 pigs survived the experiments
through. In the animal group 1with Feridex/PKH26-dual-labeled
cell transplantation and the animal group 2 with Feridex-only-
labeled cell transplantation, in vivo MRI revealed MR signal voids
along the iliofemoral artery walls in 3 of 5 pigs in both animal
groups (grade 2 at 60%), whereas similar findings were not seen in
the control iliofemoral artery walls (0%) (Figure 2). Histology with
H&E staining showed intimal hyperplasia at the injury sites. The
intima-to-wall ratio was significantly higher with the intima-
injured arteries than with the uninjured arteries (0.2060.09 vs.
0.0560.02, P,0.01). Fluorescent microscopy detected PKH26-
positive cells as red-fluorescent dots in the injured arterial walls in
3 of 5 pigs for animal group 1. Prussian blue staining and
immunofluorescence with anti-dextran staining displayed Feridex-
positive BM cells as blue-colored spots and green-fluorescent dots,
respectively, in 3 of 5 pigs for both animal groups 1 and 2, which
were consistent with the MRI and PKH26 findings. These
histologic findings were not seen in the control iliofemoral arteries
(Figure 3).
Discussion
It has become clear that, in order to successfully apply cell-based
therapy in either experimental or clinical setting, one need to
monitor, in vivo, the migration of the transplanted cells.
Developments of molecular-cellular imaging techniques enable
visualization of cells and their biological activities, such as cell
migration [8]. To date, the most commonly-used method for MRI
tracking of cell transplantation is to pre-label the cells with various
MRI-detectable agents, such as superparamagnetic iron oxide [9],
gadolinium [10], fluorine [11], or manganese [12]. Recent efforts
have been made using T1 MRI contrast medium for cell labeling,
which enabled to not only detect high MRI signal by the labeled
cells, but also outline the anatomic structures of the cell-targeted
arterial walls [13].
Previous MRI studies using mouse models have demonstrated
successfully monitoring of allo-transplantation of Feridex-labeled
BM cells homing to the sites of injured arteries or atherosclerotic
plaques [6,7]. However, allo-transplantation of cells requires lethal
irradiation of recipients, which has potential impact on vascular
cell viability [14]. Most critically, allo-transplantation may cause
immunologic rejection and thereby cannot be directly applied in
clinical practice on humans. To the best of our knowledge, the
current study is the first attempt to validate the feasibility of using
clinical 3.0T MRI to track the migration of autotransplanted BM
cells to the injured arteries in large animals.
In this study, we first evaluated the possibility of efficiently
labeling BM cells with Feridex and/or PKH26, which confirmed
that most of labeled cells maintained their normal metabolic
activity. We then further validated the feasibility using clinical
3.0T MRI to monitor auto-transplantation of these labeled cells
migrated to the injured arteries, which were confirmed by
subsequent histologic correlation. We achieved the successful
BM cell transplantation in 60% cases, which is similar to the
results published by another group using allo-transplantation of
BM cells [15]. The reasons for such low engraftment rates are not
clear so far, perhaps due to the death of some cells during their
handling and transplantation.
In additional to the surface MR coils, we used an MR imaging-
guidewire (MRIG). The placement of the MRIG into the
iliofemoral veins enabled us to not only avoid the additional
mechanical injury to the artery during manipulation of the MRIG
passing through the damaged arterial segment, but also achieve
satisfactory visualization of the adjacent iliofemoral arteries under
high-resolution intravenous MR imaging. In the present study, we
also used a multi-slice improved motion-sensitized driven
equilibrium sequence (iMSDE). The iMSDE sequence is a
black-blood sequence, which can generate higher contrast-to-
noise ratio (CNR) and lower lumen signal-to-noise ratio (SNR) in
comparison to other commonly-used MR sequences, such as the
inflow saturation (IS) and double inversion-recovery (DIR)
sequences [16,17]. The iMSDE sequence can depict a clearer
artery contour than other sequences, and thus is capable to
generate high resolution 3.0T MRI of the deep-seated arterial
walls with sufficient suppression of blood signals. While the signal
void created by Feridex-labeled bone marrow cells can obscure the
morphology of the arterial lesions in T2-weighted imaging, T1-
weighted imaging can be used to image lesion morphology. In our
study, the strength of the signal voids was not found to be related
to the severities of the artery injuries.
In conclusion, this study demonstrates the capability of using a
clinical 3.0T MRI to monitor the auto-transplantation of bone
marrow cells that migrate to the injured arteries of near-human-
sized animals. Since auto-transplantation of BM cells can avoid
immunologic rejection, this technique should be translatable to
further clinical application, which may open new avenues to
effective management of atherosclerotic cardiovascular disease, the
number one killer worldwide, using MRI-integrated regenerative
medicine.
Materials and Methods
This study was divided into two components: (i) in vitro
evaluating the possibility of labeling BM cells with two agents, a
T2-MR contrast agent (Feridex) and/or a fluorescent tissue
marker (PKH26); and (ii) in vivo validating the feasibility using
MRI of Auto-Transplanted Bone Marrow Cells
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labeled BM cells migrated to the injured iliofemoral arteries of
pigs. Figure 4 illustrates the basic experimental design and steps.
Animals
Animal experiments were designed in compliance with National
Institute Health Guideline for the Care and Use of Laboratory
Animals, and the animal protocol was approved by the
Institutional Animal Care and Use Committee of University of
Washington (Approval ID 4120-01). Thirteen domestic pigs (13–
50 kg) were divided into three groups: (i) Group 1 (n=5) with
auto-transplantation of BM cells that were co-labeled with Feridex
(Bayer HealthCare Pharmaceuticals Inc., Wayne, NJ) and PKH26
(Sigma-Aldrich, St Louis, MO); (ii) Group 2 (n=5) with auto-
transplantation of BM cells labeled with Feridex only; and (iii)
Group 3 (n=3) with unlabeled cell transplantation (one pig) or no
cell transplantation (two pigs) to serve as controls.
In Vitro Evaluation
Under general anesthesia, we extracted approximately 12–
20 ml BM from bilateral iliac crests of each pig. We removed red
blood cells from BM by using a discontinuous density gradient
with Percoll solution (eBioscience, Inc., San Diego, CA), and then
collected BM cells at the density interface between 1.067 g/ml and
Figure 1. Results of in vitro studies. (a) MTS assay shows the average proliferation efficiencies are almost the same among the different groups of
BM-SPCs labeled with Feridex, PKH26, and dual agents (Feridex+PKH26), in comparison with control BM-SPCs without labeling. (b&c) Prussian-blue
staining shows Feridex-positive cells as blue color spots, which are not seen in the unlabeled (control) cells (c). (d&e) Fluorescent microscopy
demonstrates PKH26-positive BM-SPCs as red/orange-colored fluorescent dots (d), which are not visualized in unlabeled (control) BM-SPCs (e).
doi:10.1371/journal.pone.0031137.g001
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and/or PKH26 at 25 mg/ml and poly L-lysine (PLL) at 37.5 ng/
ml in QBSP-58 Medium (PeproTech Inc., Rocky Hill, NJ) using
the protocol as previously described [18,19].
The viabilities of the labeled cells were evaluated using Trypan
blue exclusion with cell counting. The cell metabolic activity was
assessed with 3-(4,5-dimethylthiazol-2-yl) -5-(3-carboxymethoxy-
phenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) using CellTiter
96 AQueous one solution cell proliferation assay (Promega,
Madison, WI) [20]. Feridex labeling efficacy was determined by
counting the labeled cells [21] after Prussian blue staining, while
PKH26 labeling efficacy determined by counting labeled cells
under a fluorescent microscope. We randomly selected five
microscope fields to count the labeled cells from six cell groups,
and then calculated the average cell labeling efficacies.
In Vivo Validation
Creation of animal models with arterial injuries. After
sedation, each pig underwent general anesthesia with inhalation of
2% isoflurane mixed with 1 L/min oxygen. Through a surgical cut-
down or percutaneous access, a Fogarty balloon (Edwards
Lifesciences , Irvine, CA) or a cutting balloon (Boston Scientific,
Natick, MA) was positioned into the iliac artery 2-cm below the
bifurcation, where intima was injured by pulling the over-inflated
Fogarty balloon or over-inflating the cutting balloon under
ultrasound imaging guidance. Each pig was created two injury sites
in either one or two iliofemoral arteries. Then, the accessed femoral
artery segment was ligated using sutures to achieve hemostasis at the
access site. One day after the endovascular intimal injury, 2.6610
7
labeled or unlabeled BM cells suspended in 10-mL phosphate-
buffered-saline were autotransplanted, via an ear vein injection, back
to the same pig from which the BM cells were extracted.
MRI. Three weeks post-cell transplantation, each pig was
imaged using a 3.0T MR scanner (Achieva, Philips Healthcare,
Best, Netherlands) to detect the BM cells migrated to the injured
iliofemoral arterial segments. MRI was performed using a surface
coil (n=13) placed at the anterior and posterior pelvic, and a
custom made 0.032-inch MR imaging-guidewire (MRIG) (n=12).
The custom-made MRIG was manufactured from a 0.032-inch
nitinol coaxial cable with an extension of 3.2-cm inner conductor
from the outer conductor. The tip of the MRIG was refined with a
solenoid spring, which facilitated the smooth advance of the
MRIG into vessels and avoided the incidence of vessel injury
during the endovascular manipulation. The proximal end of the
MRIG was connected to 3.0T MR through a matching/tuning/
decoupling circuit [22]. For MRI using MRIG, the MRIG was
placed, via a femoral vein access, into the iliofemoral vein, where
intravenous MRI of the adjacent iliofemoral artery was archived.
MR parameters included an improved motion sensitized driven
equilibrium (iMSDE) sequence for coronal and axial T2-weighted
Figure 2. Representative MRI-histology correlation for the
auto-transplantation of BM cells in pigs. (b) Near-coronal-view of
3.0T, T2-weighted MRI shows hypo-signal or signal void (between
arrows) along the left iliofemoral artery due to the migration of Feridex-
labeled BM cells to the injured left iliofemoral artery. (c) Axial-view of
intravenous 3.0T MRI shows the disappearance of the anterior wall of
the injured left iliofemoral artery (arrow). This is confirmed by histology,
showing Feridex-positive cells as blue spots with Prussian blue staining
(f). These MRI and histological findings are not seen in the uninjured
right iliofemoral artery or injured artery with no cell transplantation (a,
b-right iliofemoral artery, d, e). Neo=neointima hyperplasia; m=media.
doi:10.1371/journal.pone.0031137.g002
Figure 3. Representative MRI and corresponding histologic findings. (a–d) Animal group 1 with Feridex/PKH26-dual-labeled cell
transplantation, showing MR signal void of the iliac artery wall (arrows on a), Prussian blue-positive cells (b), dextran-positive cells (c), and PKH26-
positive cells (d), as blue and green as well as red spots or dots, respectively, in the artery wall. (e–h) Animal group 2 with Feridex-only-labeled cell
transplantation, demonstrating MR signal void of the iliac artery wall (arrows on e), Prussian blue-positive cells (f), dextran-positive cells (g) and a
negative PKH26 stain (h). (i–l) Animal group 3 (control group) with unlabeled cell transplantation or no cell transplantation, showing the intact artery
wall on MRI (arrow on i), a negative Prussian blue stain (j), a negative dextran stain (k), and a negative PKH26 stain (l). V=iliac vein.
doi:10.1371/journal.pone.0031137.g003
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90uflip angle, 10 echo train length, 1006100 mm FOV, 1446140
matrix, 3 mm slice thickness, and 8 NEX. For each of iliofemoral
arteries, a total of 15–20 slices were achieved.
Histologic correlation. After achieving satisfactory MR
images, the pigs were euthanized by intravenous injections of
pentobarbital sodium (100 mg/kg). The iliofemoral arteries were
harvested and cryosectioned at 5-mm slice thickness through. We
then stained the 15–20 slices with (a) hematoxylin and eosin (H&E)
staining for histologically grading the arterial injuries; (b) Prussian
blue staining for detecting Feridex-positive cells; (c) immuno-
fluorescent staining for detecting dextran shells of Feridex; and (d)
fluorescent microscopy examination for detecting PKH26-positive
cells in the target vessel walls. Since this study mainly focused on
development of the new MR technique, we did not attempt to
examine the downstream phenotypes of the migrated BM cells.
Data analysis. MR images were analyzed with Philips
DICOM viewer software. Manifestations of the arterial walls
were divided into 2 grades: Grade 1 with intact arterial walls as a
bright ring, and Grade 2 with incomplete bright ring or missed
portion of arterial walls due to migrated Feridex/BM cell-created
MR signal void. Of H&E staining, the thickness of the intimal
hyperplasia and the artery wall was measured and the intima-to-
wall ratio (IWRinjure) was calculated and compared to IWRcontrol.
Statistics
Statistic analysis was performed using SPSS software. ANOVA
was used to compare the cell proliferation efficiencies between
labeled and controlled BM cells. Non-parametric Mann-Whitney U
test was used to compare the IWRs between injured and uninjured
artery walls. Data was expressed as mean 6 SD. A probability level
of less than 0.05 was considered statistically significant.
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